文献速递乳房整形与再造美容整形

自体脂肪移植全乳再造中外部真空扩张的中期分析

External vacuum expansion in autologous fat transfer as total breast reconstruction: Is it worth it? The interim analysis of the multicentre randomised controlled EVE trial.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2026-06-03

EVE组与对照组在增大百分比和移植物保留率上无显著差异,但EVE组不良事件更多,以皮肤相关并发症为主。

要点

  • EVE未显著改善脂肪移植增大百分比或移植物保留率
  • EVE组不良事件和严重不良事件均多于对照组,以皮肤相关为主
  • 基于中期分析,EVE在全乳再造中的临床获益仍不确定

核心结论

  • 围手术期EVE未显著改善增大百分比或移植物保留率,但增加治疗负担和更多不良事件。

主要发现

  • EVE组平均增大190.7%,对照组176.4%,校正差异14.6%(95%CI -80.0至109.1;p=0.757)。
  • EVE组移植物保留率39.3%,对照组34.9%,差异4.5%(95%CI -6.4至15.4;p=0.405)。
  • EVE组发生22例不良事件和5例严重不良事件,对照组为3例不良事件和2例严重不良事件,以皮肤相关并发症为主。

临床怎么用

  • 基于中期分析,EVE在全乳再造中的临床获益不确定,需等待纳入患者报告生活质量结局的最终分析。

局限性

  • 为中期分析,生活质量结局未分析;最终分析尚未完成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autologous fat transfer (AFT) is an emerging option for total breast reconstruction. To improve graft survival, perioperative external vacuum expansion (EVE) is used to optimise recipient-site environment. However, the efficacy of EVE and its treatment burden on women needs consideration. This interim analysis of a multicentre randomised controlled trial (RCT) evaluates the effect of EVE on volumetric outcomes and safety. METHODS: Women undergoing total breast reconstruction with AFT were randomised 2:1 to perioperative EVE or no EVE. All participants underwent three AFT sessions followed by magnetic resonance imaging (MRI)-based volumetric assessment at six months. Primary outcomes were percentage augmentation and graft retention. Secondary outcomes included (serious) adverse events (SAEs). Quality-of-life (QoL) outcomes were not analysed in this interim analysis, as reconstruction was ongoing. RESULTS: Fifty-three participants were included (EVE, N = 32; control, N = 21). Mean augmentation was 190.7% with EVE versus 176.4% without (adjusted difference 14.6%; 95% CI -80.0 to 109.1; p = 0.757). Graft retention was 39.3% and 34.9%, respectively (difference 4.5%; 95% CI -6.4 to 15.4; p = 0.405). Both outcomes showed no statistically significant between-group differences. The EVE group experienced more AEs (22 AEs and 5 SAEs) compared with the control group (three AEs and two SAEs), which were predominantly skin-related complications. CONCLUSIONS: Perioperative EVE use did not yield significant improvements in augmentation or graft retention; however, it was associated with higher treatment burden and more (S)AEs. Final analyses of our ongoing RCT, incorporating patient-reported QoL outcomes are still awaited. Based on this interim analysis, the clinical benefit of EVE in reconstructive settings remains uncertain and warrants additional research.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. van der Venne WBW, Smeins NNPM, Kuijlaars ZMA, et al. External vacuum expansion in autologous fat transfer as total breast reconstruction: Is it worth it? The interim analysis of the multicentre randomised controlled EVE trial. J Plast Reconstr Aesthet Surg. 2026. PMID: 42314328. doi:10.1016/j.bjps.2026.05.072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。